celastrol has been researched along with Carcinoma, Ductal, Pancreatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, Y | 1 |
| Deeb, D; Gao, X; Gautam, SC; Liu, Y; Pindolia, K | 1 |
2 other study(ies) available for celastrol and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Construction of a circRNA-miRNA-mRNA network to explore the pathogenesis and treatment of pancreatic ductal adenocarcinoma.
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; HL-60 Cells; Humans; Imidazoles; Leupeptins; MicroRNAs; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Pentacyclic Triterpenes; Phosphorylation; Protein Interaction Maps; RNA, Circular; RNA, Messenger; Software; Treatment Outcome; Triterpenes | 2020 |
Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Gene Knockdown Techniques; Humans; Pancreatic Neoplasms; Pentacyclic Triterpenes; Telomerase; Triterpenes | 2015 |